Bayer Collaborates with Inselspital Bern on medical imaging platform Calantic Digital Solutions

Through a subscription license agreement of this specialized platform, Inselspital will use digital applications; including artificial intelligence (AI) enabled tools for medical imaging. The platform contains apps that help radiologists and their teams improve prioritization, lesion detection, quantification and productivity, aiming to support healthcare professionals at various stages of their work, from diagnosis through treatment of their patients.

“AI has the potential to be a game-changer in healthcare and medical imaging,” said Prof. Roland Wiest, deputy director, Institute of Diagnostic and Interventional Neuroradiology, Bern University Hospital and University of Bern, Switzerland, and head of several educational initiatives in radiology to enable a wider use of AI-based technologies. “As AI is making its way into radiology, we are looking forward to joining forces with renowned experts such as Inselspital Bern to drive its adoption in clinical practice,” said Gerd Krueger, president, radiology, Bayer.

“Building on deep medical expertise across a multitude of diagnostic and therapeutic areas at Bayer, AI will continue to be a significant focus for us to help transform patient care.” “We are pleased to work with Inselspital Bern, one of the top university hospitals in Switzerland and worldwide, on offering digital solutions that can help improve productivity and patient outcomes,” said Lucia Fernandez Lopez, head of digital solutions business EMEA, Radiology, Bayer. “We are looking forward to working together with this renowned institution to prove the value of Calantic Digital Solutions to radiology and the entire health system.”

Calantic Digital Solutions is a suite of digital radiology AI-enabled applications that assist radiologists and their teams at critical steps within a patient’s treatment journey. The offering is orchestrated by body region, initially focusing on thoracic and neurological diseases. Bayer recently announced new collaboration agreements with app developers to broaden the options already available on the platform by including tools designed to help with cardiac, breast and prostate imaging.